Butterfly Network, Inc. (BFLY) develops handheld ultrasound systems built on proprietary ultrasound-on-chip technology. Its point-of-care devices focus on portability and affordability for clinicians. Recent expansions include software and platform offerings such as the Butterfly Embedded program and the Butterfly Garden AI marketplace.
The $11 target matters because it sits just above the 52-week high of $10.05 and aligns with the most bullish analyst forecast. It also represents a roughly 15% gain from recent levels near $9.50, offering a clear benchmark without appearing overly distant.
The stock has recovered sharply from its 52-week low of $1.34, driven by improved sentiment around the platform transition and better fundamentals. In the second quarter, Butterfly Network posted record revenue of approximately $32.6 million and raised its full-year 2026 outlook to a range of roughly $119 million to $123 million. Analysts project continued double-digit revenue growth into 2027.
Wall Street’s consensus rating stands at “Strong Buy,” with average 12-month price targets ranging from $9.31 to $10.50 depending on the source. Individual targets span from about $5.25 on the low side to $11 on the high end, highlighting differing views on the pace of scaling and profitability.
Several developments could support a move toward $11. A co-development and licensing agreement with Midjourney delivered a $15 million upfront fee plus ongoing annual license revenue, adding a software-style income stream. Management has emphasized Butterfly Embedded for integration into third-party devices and the Butterfly Garden ecosystem for partner-developed, FDA-cleared AI applications.
Government opportunities via FedRAMP certification could open doors with agencies such as the Department of Veterans Affairs. The Home & Community Care initiative, aimed at at-home monitoring for conditions like congestive heart failure, offers another long-term avenue. Sustained revenue beats and progress on these newer segments would provide the fundamental backing needed for higher prices. I also checked comparable setups using Tickeron’s AI Screener to see how the stock stacks up against peers.
Profitability remains the primary challenge. Butterfly Network continues to report net losses and negative earnings per share, with elevated research and development costs pressuring results. Because the stock trades mainly on growth expectations, any revenue slowdown, delayed enterprise deals, or guidance miss could weigh on the valuation.
Some independent models suggest the shares trade modestly above estimated fair value, implying that optimistic scenarios may already be priced in. The spread in analyst targets reflects this uncertainty, with several firms maintaining targets of $6 or lower.
From a technical standpoint, the $10.05 area serves as the main resistance level. A decisive break above it would be necessary for the $11 target to come into realistic reach. On the downside, the $9 psychological level and the broader $8 zone have acted as support where buyers have stepped in previously. Holding above $9 would help maintain the longer-term recovery trend.
In my analysis of BFLY and similar names, I regularly turn to Tickeron’s AI Daily Buy/Sell Signals to track shifting momentum across thousands of stocks and ETFs. The tool applies artificial intelligence to market conditions and technical behavior, delivering Buy, Sell, or Hold signals that help identify emerging trends without constant manual chart review.
A move to $11 for Butterfly Network looks ambitious yet attainable given the stock’s position only about 15% below that level, its Strong Buy consensus, record revenue, raised guidance, and expanding platform strategy. These elements provide legitimate support for further appreciation.
That said, the path is not guaranteed. The company is still unprofitable, valuation appears elevated to some models, and the stock must first clear the $10.05 resistance. Investors should track quarterly revenue growth, movement toward profitability, commercialization of the Embedded and Garden platforms, and whether prices hold above key support zones. Reaching $11 will likely hinge on steady execution across these areas.
Traders looking to follow BFLY alongside other opportunities can explore Tickeron’s AI Daily Buy/Sell Signals for structured, AI-driven insights into momentum and trend shifts. I find it helpful for staying objective when evaluating resistance levels and entry points.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BFLY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 36 of 41 cases where BFLY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 65 cases where BFLY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
Following a +6.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where BFLY advanced for three days, in 186 of 227 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Momentum Indicator moved below the 0 level on August 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BFLY as a result. In 68 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
The Moving Average Convergence Divergence Histogram (MACD) for BFLY turned negative on August 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 42 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
BFLY moved below its 50-day moving average on September 02, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BFLY crossed bearishly below the 50-day moving average on September 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BFLY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for BFLY entered a downward trend on September 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. BFLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.965) is normal, around the industry mean (10.728). P/E Ratio (0.000) is within average values for comparable stocks, (68.607). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.677). BFLY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (17.794) is also within normal values, averaging (39.507).
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFLY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry MedicalNursingServices